Literature DB >> 10875929

H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein.

S Runge1, F C Nielsen, J Nielsen, J Lykke-Andersen, U M Wewer, J Christiansen.   

Abstract

H19 RNA is a major oncofetal 2.5-kilobase untranslated RNA of unknown function. The maternally expressed H19 gene is located 90 kilobase pairs downstream from the paternally expressed insulin-like growth factor II (IGF-II) gene on human chromosome 11 and mouse chromosome 7; and due to their reciprocal imprinting and identical spatiotemporal expression, it is assumed that the two genes are functionally coupled. Here we show that human H19 RNA contains four attachment sites for the oncofetal IGF-II mRNA-binding protein (IMP) with apparent K(d) values in the 0.4-1.3 nm range. The multiple attachment sites are clustered within a 700-nucleotide segment encoded by exons 4 and 5. This 3'-terminal segment targets H19 RNA to lamellipodia and perinuclear regions in dispersed fibroblasts where IMP is also localized. The results suggest that IMP participates in H19 RNA localization and provides a link between the IGF-II and H19 genes at post-transcriptional events during mammalian development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875929     DOI: 10.1074/jbc.M001156200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  The non-coding RNAs as riboregulators.

Authors:  V A Erdmann; M Z Barciszewska; M Szymanski; A Hochberg; N de Groot; J Barciszewski
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability.

Authors:  Jacob Nielsen; Mette Ahm Kristensen; Martin Willemoës; Finn Cilius Nielsen; Jan Christiansen
Journal:  Nucleic Acids Res       Date:  2004-08-16       Impact factor: 16.971

3.  Imp associates with squid and Hrp48 and contributes to localized expression of gurken in the oocyte.

Authors:  Cuiyun Geng; Paul M Macdonald
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

4.  RNA-binding IMPs promote cell adhesion and invadopodia formation.

Authors:  Jonas Vikesaa; Thomas V O Hansen; Lars Jønson; Rehannah Borup; Ulla M Wewer; Jan Christiansen; Finn C Nielsen
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

5.  VICKZ proteins mediate cell migration via their RNA binding activity.

Authors:  Froma Oberman; Kinneret Rand; Yael Maizels; Ariel M Rubinstein; Joel K Yisraeli
Journal:  RNA       Date:  2007-07-24       Impact factor: 4.942

6.  Interrogating translational efficiency and lineage-specific transcriptomes using ribosome affinity purification.

Authors:  Pingzhu Zhou; Yijing Zhang; Qing Ma; Fei Gu; Daniel S Day; Aibin He; Bin Zhou; Jing Li; Sean M Stevens; Daniel Romo; William T Pu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

7.  EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.

Authors:  Xianglan Zhang; Im-Hee Jung; Young Sun Hwang
Journal:  Tumour Biol       Date:  2015-09-19

8.  Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.

Authors:  Valerie N Barton; Andrew M Donson; Diane K Birks; Bette K Kleinschmidt-DeMasters; Michael H Handler; Nicholas K Foreman; Sarah Z Rush
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

9.  ZBP1 recognition of beta-actin zipcode induces RNA looping.

Authors:  Jeffrey A Chao; Yury Patskovsky; Vivek Patel; Matthew Levy; Steven C Almo; Robert H Singer
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

10.  Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly.

Authors:  Yongdong Zhou; Liwei Rong; Jennifer Lu; Qinghua Pan; Chen Liang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.